From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention.
- Published in:
- Allergy & Asthma Proceedings, 2025, v. 46, n. 3, p. 161, doi. 10.2500/aap.2025.46.250030
- By:
- Publication type:
- Article
Works by Bellanti, Joseph A.
Results: 154
1
2
IL-19 Up-Regulates Mucin 5AC Production in Patients With Chronic Rhinosinusitis via STAT3 Pathway.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01682
- By:
- Publication type:
- Article
3
Tc17/IL-17A Up-Regulated the Expression of MMP-9 via NF-κB Pathway in Nasal Epithelial Cells of Patients With Chronic Rhinosinusitis.
- Published in:
- Frontiers in Immunology, 2018, p. N.PAG, doi. 10.3389/fimmu.2018.02121
- By:
- Publication type:
- Article
4
Specific Impairment of Cell-Mediated Immunity in Mothers of Infants with Congenital Infection Due to Cytomegalovirus.
- Published in:
- Journal of Infectious Diseases, 1977, v. 135, n. 3, p. 386, doi. 10.1093/infdis/135.3.386
- By:
- Publication type:
- Article
5
15Chromium-Release Microassay Technique for Cell-Mediated Immunity to Mumps Virus: Correlation with Humoral and Delayed-Type Skin Hypersensitivity Responses.
- Published in:
- Journal of Infectious Diseases, 1976, v. 134, n. 6, p. 546
- By:
- Publication type:
- Article
6
Neutralizing Antibody and Lymphocyte-Mediated, Colony-Forming Inhibition Responses to Measles Infection in Cercopithecus aethiops Monkeys.
- Published in:
- Journal of Infectious Diseases, 1975, v. 132, n. 5, p. 511
- By:
- Publication type:
- Article
7
Development of Specific Cellular and Humoral Immune Responses in Children Immunized with Live Rubella Virus Vaccine.
- Published in:
- Journal of Infectious Diseases, 1974, v. 130, n. 5, p. 449
- By:
- Publication type:
- Article
8
Studies of Cell-mediated Immunity to Measles Virus by in Vitro Lymphocyte-mediated Cytotoxicity.
- Published in:
- Journal of Infectious Diseases, 1974, v. 129, n. 3, p. 233
- By:
- Publication type:
- Article
9
Dose-response studies of methylated and nonmethylated CpG ODNs from Bifidobacterium longum subsp. infantis for optimizing Treg cell stimulation.
- Published in:
- Allergy & Asthma Proceedings, 2025, v. 46, n. 2, p. 98, doi. 10.2500/aap.2025.46.250001
- By:
- Publication type:
- Article
10
Type 2 inflammation: A unifying pathway in allergic diseases and a call to action for the Allergist-Immunologist.
- Published in:
- Allergy & Asthma Proceedings, 2025, v. 46, n. 2, p. 79, doi. 10.2500/aap.2025.46.250006
- By:
- Publication type:
- Article
11
Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease.
- Published in:
- Allergy & Asthma Proceedings, 2025, v. 46, n. 1, p. e13, doi. 10.2500/aap.2025.46.240100
- By:
- Publication type:
- Article
12
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches.
- Published in:
- Allergy & Asthma Proceedings, 2025, v. 46, n. 1, p. 1, doi. 10.2500/aap.2025.46.240102
- By:
- Publication type:
- Article
13
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis.
- Published in:
- Allergy & Asthma Proceedings, 2024, v. 45, n. 6, p. 438, doi. 10.2500/aap.2024.45.240040
- By:
- Publication type:
- Article
14
Integrating innovation and shared decision-making in allergy and immunology practice.
- Published in:
- Allergy & Asthma Proceedings, 2024, v. 45, n. 6, p. 395, doi. 10.2500/aap.2024.45.240089
- By:
- Publication type:
- Article
15
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT).
- Published in:
- Allergy & Asthma Proceedings, 2024, v. 45, n. 5, p. 291, doi. 10.2500/aap.2024.45.240062
- By:
- Publication type:
- Article
16
Perspectives on allergic diseases: From asthma to food allergy – A continuing challenge for the AllergistImmunologist.
- Published in:
- Allergy & Asthma Proceedings, 2024, v. 45, n. 4, p. 215, doi. 10.2500/aap.2024.45.240038
- By:
- Publication type:
- Article
17
Exploring the spectrum of allergic disorders that continue to challenge the Allergist-Immunologist: From hereditary angioedema to metal implant allergy.
- Published in:
- Allergy & Asthma Proceedings, 2024, v. 45, n. 3, p. 143, doi. 10.2500/aap.2024.45.240015
- By:
- Publication type:
- Article
18
Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing.
- Published in:
- Allergy & Asthma Proceedings, 2024, v. 45, n. 2, p. 84, doi. 10.2500/aap.2024.45.230089
- By:
- Publication type:
- Article
19
Allergic diseases in children: A continuing challenge for the Allergist-Immunologist.
- Published in:
- Allergy & Asthma Proceedings, 2024, v. 45, n. 2, p. 81, doi. 10.2500/aap.2024.45.240003
- By:
- Publication type:
- Article
20
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs.
- Published in:
- Allergy & Asthma Proceedings, 2024, v. 45, n. 1, p. 1, doi. 10.2500/aap.2024.45.230086
- By:
- Publication type:
- Article
21
Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
22
Navigating the uncharted waters of chronic urticaria: A perplexing challenge for the allergist-immunologist.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
23
The PANDAS/PANS disorders. Is it time for more allergist-immunologists to get involved?
- Published in:
- Allergy & Asthma Proceedings, 2023, v. 44, n. 5, p. 296, doi. 10.2500/aap.2023.44.230029
- By:
- Publication type:
- Article
24
The challenge of neurologic disease for the allergist/immunologist.
- Published in:
- Allergy & Asthma Proceedings, 2023, v. 44, n. 5, p. 293, doi. 10.2500/aap.2023.44.230053
- By:
- Publication type:
- Article
25
The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist.
- Published in:
- Allergy & Asthma Proceedings, 2023, v. 44, n. 4, p. 220, doi. 10.2500/aap.2023.44.230030
- By:
- Publication type:
- Article
26
A trajectory of the FDA approval of the first vaccine targeting RSV: A greek tragedy with a happy ending.
- Published in:
- Allergy & Asthma Proceedings, 2023, v. 44, n. 4, p. 217, doi. 10.2500/aap.2023.44.230037
- By:
- Publication type:
- Article
27
A tribute to allergy and immunology fellowship training program directors and to the fellows they train.
- Published in:
- Allergy & Asthma Proceedings, 2023, v. 44, n. 3, p. 155, doi. 10.2500/aap.2023.44.230017
- By:
- Publication type:
- Article
28
The complexities of allergic diseases continue to challenge the allergist-immunologist.
- Published in:
- 2023
- By:
- Publication type:
- Editorial
29
Allergy and immunology: At the crossroad of inflammation and disease.
- Published in:
- Allergy & Asthma Proceedings, 2023, v. 44, n. 1, p. 1, doi. 10.2500/aap.2023.44.220094
- By:
- Publication type:
- Article
30
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors.
- Published in:
- Allergy & Asthma Proceedings, 2022, v. 43, n. 6, p. 471, doi. 10.2500/aap.2022.43.220081
- By:
- Publication type:
- Article
31
Monkeypox viral infection and disease: A challenge for the allergist-immunologist.
- Published in:
- Allergy & Asthma Proceedings, 2022, v. 43, n. 6, p. 509, doi. 10.2500/aap.2022.43.220075
- By:
- Publication type:
- Article
32
The long COVID syndrome: A conundrum for the allergist/immunologist.
- Published in:
- Allergy & Asthma Proceedings, 2022, v. 43, n. 5, p. 368, doi. 10.2500/aap.2022.43.220059
- By:
- Publication type:
- Article
33
Asthma biomarkers and COVID-19 continue to dominate current medical issues.
- Published in:
- Allergy & Asthma Proceedings, 2022, v. 43, n. 5, p. 363, doi. 10.2500/aap.2022.43.220062
- By:
- Publication type:
- Article
34
Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines.
- Published in:
- Allergy & Asthma Proceedings, 2022, v. 43, n. 5, p. 419, doi. 10.2500/aap.2022.43.220045
- By:
- Publication type:
- Article
35
Essentials of allergen immunotherapy: A primer for the practitioner.
- Published in:
- Allergy & Asthma Proceedings, 2022, v. 43, n. 4, p. 245, doi. 10.2500/aap.2022.43.220039
- By:
- Publication type:
- Article
36
Long COVID: A proposed hypothesis-driven model of viral persistence for the pathophysiology of the syndrome.
- Published in:
- Allergy & Asthma Proceedings, 2022, v. 43, n. 3, p. 187, doi. 10.2500/aap.2022.43.220018
- By:
- Publication type:
- Article
37
Eosinophilic esophagitis: from discovery to effective treatment.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
38
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/ immunologist.
- Published in:
- Allergy & Asthma Proceedings, 2022, v. 43, n. 2, p. 93, doi. 10.2500/aap.2022.43.220008
- By:
- Publication type:
- Article
39
SARS-CoV-2 infection and the human immune system: A continuing journey of discovery.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
40
Evaluation and management of adverse reactions to the COVID-2019 vaccines.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
41
COVID-19 vaccines and vaccine hesitancy: Role of the allergist/immunologist in promotion of vaccine acceptance.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 5, p. 386, doi. 10.2500/aap.2021.42.210063
- By:
- Publication type:
- Article
42
Vaccine preventable diseases, vaccine hesitancy, and COVID-19: A role for the allergist/immunologist.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 5, p. 365, doi. 10.2500/aap.2021.42.210070
- By:
- Publication type:
- Article
43
COVID-19: A continuing challenge for the allergist/immunologist.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 4, p. 263, doi. 10.2500/aap.2021.42.210049
- By:
- Publication type:
- Article
44
Studies of mitochondrial and nuclear DNA released from food allergen–activated neutrophils. Implications for non–IgE food allergy.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 3, p. e59, doi. 10.2500/aap.2021.42.210021
- By:
- Publication type:
- Article
45
Is nutraceutical supplementation appropriate for COVID-19 management?
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 3, p. e103, doi. 10.2500/aap.2021.42.210030
- By:
- Publication type:
- Article
46
The allergist and IgE: The realization that allergic diseases are not all IgE mediated.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 3, p. 183, doi. 10.2500/aap.2021.42.210037
- By:
- Publication type:
- Article
47
Hereditary angioedema again revisited.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
48
COVID-19 in children: Pathogenesis and current status.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 1, p. 8, doi. 10.2500/aap.2021.42.200104
- By:
- Publication type:
- Article
49
The war on infectious diseases: COVID-19 vaccines and the public: Challenges and solutions.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
50
The challenge of COVID-19 that permeates the practice of allergy/immunology.
- Published in:
- 2021
- By:
- Publication type:
- Editorial